# Cytodyn Z Score

 CYDY Stock USD 0.27  0.03  10.00%
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Cytodyn Piotroski F Score and Cytodyn Valuation analysis.
 Cytodyn

## Cytodyn Z Score Analysis

Cytodyn's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 Z Score = Sum Of 5 Factors
More About Z Score | All Equity Analysis

### Current Cytodyn Z Score

-22.7
Most of Cytodyn's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cytodyn is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
 Compare to competition Predict Cytodyn
In accordance with the company's disclosures, Cytodyn has a Z Score of -22.7. This is 436.3% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.

## Cytodyn Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cytodyn's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cytodyn could also be used in its relative valuation, which is a method of valuing Cytodyn by comparing valuation metrics of similar companies.
Cytodyn is currently under evaluation in z score category among related companies.

## Cytodyn Fundamentals

 Return On Asset (1.48) % Current Valuation 286.7 M Shares Outstanding 832.97 M Shares Owned by Insiders 7.91 % Shares Owned by Institutions 0.09 % Price to Earning (3.14) X Price to Book 1,066 X Price to Sales 1,174 X Revenue 266 K Gross Profit (73.28 M) EBITDA (157.59 M) Net Income (210.82 M) Cash and Equivalents 4.68 M Cash per Share 0.01 X Total Debt 37.35 M Current Ratio 0.08 X Book Value Per Share (0.14) X Cash Flow from Operations (77.72 M) Earnings Per Share (0.23) X Target Price 4.0 Number of Employees 23 Beta 0.16 Market Capitalization 246.98 M Total Asset 29.18 M Retained Earnings (211.86 M) Working Capital (371.16 K) Current Asset 136.91 K Current Liabilities 508.07 K Z Score -22.7 Net Asset 29.18 M

The Macroaxis Fundamental Analysis modules help investors analyze Cytodyn's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytodyn using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytodyn based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.

## Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytodyn without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

## Did you try this?

### Run Stock Screener Now

#### Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
 All  Next Launch Module

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytodyn position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will appreciate offsetting losses from the drop in the long position's value.

### Moving together with Cytodyn

 + 0.72 ATRA Atara Biotherapeutics PairCorr

### Moving against Cytodyn

 - 0.86 SNY Sanofi ADR Earnings Call This Week PairCorr - 0.85 CABA Cabaletta Bio PairCorr - 0.81 MRK Merck Company Earnings Call This Week PairCorr - 0.77 NVS Novartis AG ADR Earnings Call This Week PairCorr
The ability to find closely correlated positions to Cytodyn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytodyn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytodyn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytodyn to buy it.
The correlation of Cytodyn is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytodyn moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytodyn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytodyn can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Continue to Cytodyn Piotroski F Score and Cytodyn Valuation analysis. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

## Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
 Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated Equity ValuationCheck real value of public entities based on technical and fundamental data Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity Content SyndicationQuickly integrate customizable finance content to your own investment portal Transaction HistoryView history of all your transactions and understand their impact on performance Global CorrelationsFind global opportunities by holding instruments from different markets Volatility AnalysisGet historical volatility and risk analysis based on latest market data
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.